Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aripiprazole in Pediatric Bipolar I Disorder
NCT00110461Phase 3Completed
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization
- Start
- Mar 2005
- Primary completion
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of aripiprazole in bipolar I disorder, sponsored by Otsuka Pharmaceutical Development & Commercialization. Started Mar 2005; status: completed.
02
Drugs
aripiprazole
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT00110461.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00110461.